(Q44349470)

2 December 2017

title

Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

2 December 2017

1 reference

1 reference

1 reference

1 reference

Ghina Ghazeeri

1

1 reference

2 December 2017

William H Kutteh

2

1 reference

2 December 2017

Michael Bryer-Ash

3

1 reference

2 December 2017

Derek Haas

4

1 reference

2 December 2017

Raymond W Ke

5

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

2 December 2017

published in

Fertility and Sterility

1 reference

2 December 2017

volume

79

1 reference

2 December 2017

issue

3

1 reference

2 December 2017

page(s)

562-566

1 reference

Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904843-4

Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904843-4

Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904843-4

Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904843-4

Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904843-4

Coronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904843-4

Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904843-4

Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904843-4

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904843-4

A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904843-4

Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904843-4

Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904843-4

The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904843-4

Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904843-4

Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904843-4

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904843-4

Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904843-4

Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904843-4

Thiazolidinediones: a new class of antidiabetic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904843-4

Troglitazone reduces plasma leptin concentration but increases hunger in NIDDM patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2904843-4

10.1016/S0015-0282(02)04843-4

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference